Wegovy is indicated for managing body weight in obese and overweight patients with weight-related health problems and treating metabolic dysfunction-associated steatohepatitis (MASH) in patients with liver fibrosis
When dose adjustment is not necessary Mild to moderate heartburn that responds to dietary changes, lifestyle modifications, or OTC medications does not require a dose change
Specifically, antidiabetic injection Ozempic (semaglutide) generated sales of DKK 64.5 billion (USD 9.6 billion) in the first half of the year, up 15% YoY, while oral tablet Rybelsus (semaglutide) delivered sales of DKK 11.3 billion (USD 1.7 billion) after 5% expansion, and weight-loss injection Wegovy(semaglutide) HCP jumped 78% to DKK 36.9 billion (USD 5.5 billion)
The results of the study were recently published in the journal Metabolites
The brand Saxenda has been discontinued by Novo Nordisk, but generic liraglutide is still available in the UK under the brand name Nevolat, which is manufactured by the pharmaceutical company Zentiva
Studies show up to 39% of total weight lost on GLP-1 medications can be lean muscle mass rather than fat